Brazil Health Regulator Sets Rules for COVID-19 Vaccine Emergency Use

RIO DE JANEIRO, BRAZIL – Brazil’s health regulator Anvisa decided on Thursday to allow temporary emergency use authorizations for COVID-19 vaccines and set rules for companies to apply for the option that did not exist in the country.

The decision will potentially allow emergency use of vaccines that are being tested in Brazil by AstraZeneca, Pfizer Inc, Johnson & Johnson’s pharmaceutical subsidiary Janssen, and China’s Sinovac Biotech.

Source: Reuters

Related coverage: Brazil Aims to Vaccinate Entire Population Against COVID-19 in 2021 · Report: Murders of Transgender, Indigenous, Environmental Activists Increase in 2020 · Covid-19 Vaccine: Pfizer's Proposal to Address Cooling Challenge in Brazil: Dry Ice · Bolsonaro Says Brazil Is Experiencing 'Tail end' of Pandemic Despite Death Surge

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Brazil runoff, Sunday, October 25: Brazil runoff date. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.